Literature DB >> 22918031

Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

Paula E Goines1, Paul Ashwood.   

Abstract

Autism spectrum disorders (ASD) are neurodevelopmental diseases that affect an alarming number of individuals. The etiological basis of ASD is unclear, and evidence suggests it involves both genetic and environmental factors. There are many reports of cytokine imbalances in ASD. These imbalances could have a pathogenic role, or they may be markers of underlying genetic and environmental influences. Cytokines act primarily as mediators of immunological activity but they also have significant interactions with the nervous system. They participate in normal neural development and function, and inappropriate activity can have a variety of neurological implications. It is therefore possible that cytokine dysregulation contributes directly to neural dysfunction in ASD. Further, cytokine profiles change dramatically in the face of infection, disease, and toxic exposures. Imbalances in cytokines may represent an immune response to environmental contributors to ASD. The following review is presented in two main parts. First, we discuss select cytokines implicated in ASD, including IL-1Β, IL-6, IL-4, IFN-γ, and TGF-Β, and focus on their role in the nervous system. Second, we explore several neurotoxic environmental factors that may be involved in the disorders, and focus on their immunological impacts. This review represents an emerging model that recognizes the importance of both genetic and environmental factors in ASD etiology. We propose that the immune system provides critical clues regarding the nature of the gene by environment interactions that underlie ASD pathophysiology.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918031      PMCID: PMC3554862          DOI: 10.1016/j.ntt.2012.07.006

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  349 in total

1.  Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells.

Authors:  A Rajakumar; T Chu; D E Handley; K D Bunce; B Burke; C A Hubel; A Jeyabalan; D G Peters
Journal:  Placenta       Date:  2010-11-13       Impact factor: 3.481

2.  Non-cell-autonomous action of STAT3 in maintenance of neural precursor cells in the mouse neocortex.

Authors:  Takeshi Yoshimatsu; Daichi Kawaguchi; Koji Oishi; Kiyoshi Takeda; Shizuo Akira; Norihisa Masuyama; Yukiko Gotoh
Journal:  Development       Date:  2006-05-25       Impact factor: 6.868

Review 3.  Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.

Authors:  Douglas A Kuperman; Robert P Schleimer
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

Review 4.  Current issues in organophosphate toxicology.

Authors:  Lucio G Costa
Journal:  Clin Chim Acta       Date:  2005-12-06       Impact factor: 3.786

5.  Developmental exposure to a commercial PBDE mixture, DE-71: neurobehavioral, hormonal, and reproductive effects.

Authors:  Prasada Rao S Kodavanti; Cary G Coburn; Virginia C Moser; Robert C MacPhail; Suzanne E Fenton; Tammy E Stoker; Jennifer L Rayner; Kurunthachalam Kannan; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2010-04-07       Impact factor: 4.849

6.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-08-10       Impact factor: 7.217

7.  Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development.

Authors:  J G Corbin; D Kelly; E M Rath; K D Baerwald; K Suzuki; B Popko
Journal:  Mol Cell Neurosci       Date:  1996-05       Impact factor: 4.314

8.  Subchronic effects of 2,3,7,8-TCDD or PCBs on thyroid hormone metabolism: use in risk assessment.

Authors:  A P Van Birgelen; E A Smit; I M Kampen; C N Groeneveld; K M Fase; J Van der Kolk; H Poiger; M Van den Berg; J H Koeman; A Brouwer
Journal:  Eur J Pharmacol       Date:  1995-05-26       Impact factor: 4.432

9.  Exposure to brominated flame retardant PBDE-99 affects cytoskeletal protein expression in the neonatal mouse cerebral cortex.

Authors:  Henrik Alm; Kim Kultima; Birger Scholz; Anna Nilsson; Per E Andrén; Asa Fex-Svenningsen; Lennart Dencker; Michael Stigson
Journal:  Neurotoxicology       Date:  2008-05-08       Impact factor: 4.294

10.  Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study.

Authors:  Paula E Goines; Lisa A Croen; Daniel Braunschweig; Cathleen K Yoshida; Judith Grether; Robin Hansen; Martin Kharrazi; Paul Ashwood; Judy Van de Water
Journal:  Mol Autism       Date:  2011-08-02       Impact factor: 7.509

View more
  94 in total

1.  Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma.

Authors:  Marjannie Eloi Akintunde; Melissa Rose; Paula Krakowiak; Luke Heuer; Paul Ashwood; Robin Hansen; Irva Hertz-Picciotto; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2015-07-11       Impact factor: 3.478

Review 2.  Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.

Authors:  Lena Smirnova; Helena T Hogberg; Marcel Leist; Thomas Hartung
Journal:  ALTEX       Date:  2014       Impact factor: 6.043

3.  Generation of a microglial developmental index in mice and in humans reveals a sex difference in maturation and immune reactivity.

Authors:  Richa Hanamsagar; Mark D Alter; Carina S Block; Haley Sullivan; Jessica L Bolton; Staci D Bilbo
Journal:  Glia       Date:  2017-06-15       Impact factor: 7.452

4.  Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical study.

Authors:  Alok K Sharma; Nandini Gokulchandran; Pooja P Kulkarni; Hemangi M Sane; Ridhima Sharma; Alitta Jose; Prerna B Badhe
Journal:  Am J Stem Cells       Date:  2020-12-25

5.  Early Life Stress Alters Adult Inflammatory Responses in a Mouse Model for Depression.

Authors:  Christine F Hohmann; Gabi Odebode; Lalith Naidu; Michael Koban
Journal:  Ann Psychiatry Ment Health       Date:  2017-03-06

6.  Autism genes keep turning up chromatin.

Authors:  Janine M Lasalle
Journal:  OA Autism       Date:  2013-06-19

Review 7.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

Review 8.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

Review 9.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

10.  Immune Endophenotypes in Children With Autism Spectrum Disorder.

Authors:  Milo Careaga; Sally Rogers; Robin L Hansen; David G Amaral; Judy Van de Water; Paul Ashwood
Journal:  Biol Psychiatry       Date:  2015-09-11       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.